Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for pediatric dental sedation
NCT04237532Phase 3Completed
- Start
- Aug 2019
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in anxiety disorder. Started Aug 2019; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT04237532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04237532.